Cancer stem cells in osteosarcoma
Por:
Brown, HK, Tellez-Gabriel, M, Heymann, D
Publicada:
1 feb 2017
Resumen:
Osteosarcoma is the most common primary bone tumour in children and adolescents and advanced osteosarcoma patients with evidence of metastasis share a poor prognosis. Osteosarcoma frequently gains resistance to standard therapies highlighting the need for improved treatment regimens and identification of novel therapeutic targets. Cancer stem cells (CSC) represent a sub-type of tumour cells attributed to critical steps in cancer including tumour propagation, therapy resistance, recurrence and in some cases metastasis. Recent published work demonstrates evidence of cancer stem cell phenotypes in osteosarcoma with links to drug resistance and tumorigenesis. In this review we will discuss the commonly used isolation techniques for cancer stem cells in osteosarcoma as well as the identified biochemical and molecular markers. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Filiaciones:
Brown, HK:
Univ Sheffield, Sch Med, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
Univ Sheffield, INSERM, European Associated Lab, Sarcoma Res Unit,Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
Tellez-Gabriel, M:
Hosp Santa Creui St Pau, Inst Invest Biomed IBB St Pau, Lab Hematol Oncol & Transplantes, Barcelona 08025, Spain
Heymann, D:
Univ Sheffield, Sch Med, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
Univ Sheffield, INSERM, European Associated Lab, Sarcoma Res Unit,Med Sch, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England
Univ Nantes, Fac Med, INSERM,Equipe Ligue 2012, UMR 957,Pathophysiol Bone Resorpt & Therapy Prima, F-44035 Nantes, France
Green Accepted
|